コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ass of drugs recently described as selective estrogen receptor modulators.
2 and retinoid X receptor alpha with selective estrogen receptor modulators.
3 ssified as both phytoestrogens and selective estrogen receptor modulators.
4 ) have precipitated a search for alternative estrogen receptor modulators.
5 ogenic actions, characteristics of selective estrogen receptor modulators.
6 nic and antiestrogenic activity of selective estrogen receptor modulators.
7 cer are associated with the use of selective estrogen receptor modulators.
8 Leu-Cys)-Arg-Leu-Leu-Gln-NH2 (peptidomimetic estrogen receptor modulator 1), binds with a Ki of 25 nM
10 ity of ERalpha can be regulated by selective estrogen receptor modulators, a new class of drugs whose
11 tor degeneration that tamoxifen, a selective estrogen receptor modulator and a drug previously linked
14 the identification of two structurally novel estrogen receptor modulators and the accurate prediction
15 the determination of idoxifene, a selective estrogen receptor modulator, and its pyrrolidinone metab
16 d androgen dehydroepiandrosterone, selective estrogen receptor modulators, and the prolactin inhibito
21 ons among benzothiophene and triarylethylene estrogen receptor modulators can be ascribed to discrete
22 (i.e., agonistic) pharmacology of selective estrogen receptor modulator drugs in this pathway report
27 H) trial showed that raloxifene, a selective estrogen receptor modulator, had no overall effect on th
29 stic differences between different selective estrogen receptor modulators have been translated into i
31 in the brain, including the use of selective estrogen receptor modulators, high soy diets, or isoflav
33 ta and differentially regulated by selective estrogen receptor modulators in a cell line-dependent ma
34 ues can be used for the analysis of selected estrogen receptor modulators in human plasma where more
35 the membrane impermeant E2-BSA and selective estrogen receptor modulators, including a new diphenylac
39 raloxifene (Ral), which is also a selective estrogen receptor modulator, is a complete antiestrogen
43 d to test the ability of the novel selective estrogen receptor modulator lasofoxifene (LAS) to inhibi
46 rapeutic potential of tamoxifen, a selective estrogen receptor modulator, on estrogen-induced lupus.
47 examine the effects of LY117018, a selective estrogen receptor modulator, on peripheral nerve regener
49 uated the effects of toremifene, a selective estrogen-receptor modulator, on fasting serum lipid leve
50 in combination with more effective selective estrogen receptor modulators or selective receptor downr
52 ratory reported that raloxifene, a selective estrogen receptor modulator, promoted regression of high
53 Administration of tamoxifen, a selective estrogen-receptor modulator, restored fertility to the D
57 fene, tamoxifen, and nonusers of a selective estrogen receptor modulator (SERM) in the general popula
58 thylene bisphenol analogues of the selective estrogen receptor modulator (SERM) tamoxifen were synthe
59 fficient asymmetric synthesis of a selective estrogen receptor modulator (SERM) that has a dihydroben
60 xifene (BZA) is a third-generation selective estrogen receptor modulator (SERM) that has been approve
61 xyphenyl)]be nzo[b]thiophene) is a selective estrogen receptor modulator (SERM) that is a potent estr
62 eplacement therapy (CRT) (n = 16), selective estrogen receptor modulator (SERM) therapy (n = 8), and
63 benzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM) which is currently un
66 SP500263, a novel next-generation selective estrogen receptor modulator (SERM), tamoxifen, and ralox
67 st cancer therapeutic, is a tissue-selective estrogen receptor modulator (SERM), which acts as an ant
68 -a novel, potent, third-generation selective estrogen receptor modulator (SERM)-because this benzothi
71 We tested whether the therapeutic selective estrogen receptor modulators (SERM), raloxifene and tamo
72 , but surprisingly antagonists and selective estrogen receptor modulators (SERMs) activated the AF-2
73 nificant recent findings regarding selective estrogen receptor modulators (SERMs) and selective andro
74 uvant endocrine therapy, including selective estrogen receptor modulators (SERMs) and/or aromatase in
77 l activity of natural estrogens or selective estrogen receptor modulators (SERMs) has not been determ
79 itional approaches to discovery of selective estrogen receptor modulators (SERMs) have relied on ER b
80 Tamoxifen and its analogues act as selective estrogen receptor modulators (SERMs) in women, with estr
82 enic and antiestrogenic effects of selective estrogen receptor modulators (SERMs) is thought to under
88 gen's action and determine whether selective estrogen receptor modulators (SERMs) such as tamoxifen h
89 the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen and ralox
90 e of a class of compounds known as selective estrogen receptor modulators (SERMs) that possess estrog
93 he ovariectomized rat by estrogen, selective estrogen receptor modulators (SERMs), and bisphosphonate
94 rogram aimed at the development of selective estrogen receptor modulators (SERMs), novel chromene sca
95 eral FDA-approved drugs, including selective estrogen receptor modulators (SERMs), possess selective
101 n action at the estrogen receptor (selective estrogen receptor modulators (SERMs]); or (2) inhibit es
102 a key determinant of estrogen and selective estrogen receptor modulator signaling in the ERalpha/AP-
103 enyl)-propionitrile (DPN), and the selective estrogen receptor modulator tamoxifen (Tam), inhibit est
104 promoted hormone resistance to the selective estrogen receptor modulator tamoxifen and selective estr
110 or breast cancer-specifically, the selective estrogen receptor modulators tamoxifen and raloxifene.
112 ects on uterine development of the selective estrogen receptor modulators, tamoxifen, toremifene, and
113 Raloxifene hydrochloride is a selective estrogen receptor modulator that has antiestrogenic effe
116 Phytoestrogens may act as natural selective estrogen receptor modulators that elicit distinct clinic
117 ne and TSE-424 are investigational selective estrogen receptor modulators that have been shown to be
119 ion, tamoxifen and raloxifene, two selective estrogen receptor modulators that have protective effect
121 inhibitors, fenretinide, or other selective estrogen receptor modulators to lower BC risk is not rec
122 tate the design of tissue-specific selective estrogen receptor modulators to treat breast cancers and
124 benzothiophene raloxifene, 1, is a selective estrogen receptor modulator which is currently under cli
126 ell defined forms of estrogens and selective estrogen receptor modulators will continue to provide no
127 s may provide means to develop new selective estrogen receptor modulators with improved profiles.
128 soflavones are naturally occurring selective estrogen receptor modulators, with potential bone protec
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。